Global Bile Duct Cancer Drug Market Professional Survey Report 2019

Table of Contents

Executive Summary

1 Industry Overview of Bile Duct Cancer Drug

• 1.1 Definition of Bile Duct Cancer Drug
• 1.2 Bile Duct Cancer Drug Segment by Type
  • 1.2.1 Global Bile Duct Cancer Drug Production Growth Rate Comparison by Types (2014-2025)
  • 1.2.2 Cabozantinib S-malate
  • 1.2.3 Elpamotide
  • 1.2.4 Exatecan Mesylate
  • 1.2.5 LY-2801653
  • 1.2.6 NUC-1031
  • 1.2.7 Others
• 1.3 Bile Duct Cancer Drug Segment by Applications
  • 1.3.1 Global Bile Duct Cancer Drug Consumption Comparison by Applications (2014-2025)
  • 1.3.2 Hospital
  • 1.3.3 Clinic
  • 1.3.4 Others
• 1.4 Global Bile Duct Cancer Drug Overall Market
  • 1.4.1 Global Bile Duct Cancer Drug Revenue (2014-2025)
  • 1.4.2 Global Bile Duct Cancer Drug Production (2014-2025)
  • 1.4.3 North America Bile Duct Cancer Drug Status and Prospect (2014-2025)
  • 1.4.4 Europe Bile Duct Cancer Drug Status and Prospect (2014-2025)
  • 1.4.5 China Bile Duct Cancer Drug Status and Prospect (2014-2025)
  • 1.4.6 Japan Bile Duct Cancer Drug Status and Prospect (2014-2025)
  • 1.4.7 Southeast Asia Bile Duct Cancer Drug Status and Prospect (2014-2025)
  • 1.4.8 India Bile Duct Cancer Drug Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis

• 2.1 Raw Material and Suppliers
• 2.2 Manufacturing Cost Structure Analysis of Bile Duct Cancer Drug
• 2.3 Manufacturing Process Analysis of Bile Duct Cancer Drug
• 2.4 Industry Chain Structure of Bile Duct Cancer Drug

3 Development and Manufacturing Plants Analysis of Bile Duct Cancer Drug

• 3.1 Capacity and Commercial Production Date
• 3.2 Global Bile Duct Cancer Drug Manufacturing Plants Distribution
• 3.3 Major Manufacturers Technology Source and Market Position of Bile Duct Cancer Drug
• 3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers

• 4.1 Bile Duct Cancer Drug Production and Capacity Analysis
• 4.2 Bile Duct Cancer Drug Revenue Analysis
• 4.3 Bile Duct Cancer Drug Price Analysis
• 4.4 Market Concentration Degree

5 Bile Duct Cancer Drug Regional Market Analysis

• 5.1 Bile Duct Cancer Drug Production by Regions
  • 5.1.1 Global Bile Duct Cancer Drug Production by Regions
  • 5.1.2 Global Bile Duct Cancer Drug Revenue by Regions
• 5.2 Bile Duct Cancer Drug Consumption by Regions
• 5.3 North America Bile Duct Cancer Drug Market Analysis
  • 5.3.1 North America Bile Duct Cancer Drug Production
  • 5.3.2 North America Bile Duct Cancer Drug Revenue
  • 5.3.3 Key Manufacturers in North America
  • 5.3.4 North America Bile Duct Cancer Drug Import and Export
• 5.4 Europe Bile Duct Cancer Drug Market Analysis
  • 5.4.1 Europe Bile Duct Cancer Drug Production
  • 5.4.2 Europe Bile Duct Cancer Drug Revenue
  • 5.4.3 Key Manufacturers in Europe
  • 5.4.4 Europe Bile Duct Cancer Drug Import and Export
• 5.5 China Bile Duct Cancer Drug Market Analysis
  • 5.5.1 China Bile Duct Cancer Drug Production
  • 5.5.2 China Bile Duct Cancer Drug Revenue
  • 5.5.3 Key Manufacturers in China
  • 5.5.4 China Bile Duct Cancer Drug Import and Export
• 5.6 Japan Bile Duct Cancer Drug Market Analysis
  • 5.6.1 Japan Bile Duct Cancer Drug Production
  • 5.6.2 Japan Bile Duct Cancer Drug Revenue
  • 5.6.3 Key Manufacturers in Japan
  • 5.6.4 Japan Bile Duct Cancer Drug Import and Export
• 5.7 Southeast Asia Bile Duct Cancer Drug Market Analysis
  • 5.7.1 Southeast Asia Bile Duct Cancer Drug Production
  • 5.7.2 Southeast Asia Bile Duct Cancer Drug Revenue
  • 5.7.3 Key Manufacturers in Southeast Asia
  • 5.7.4 Southeast Asia Bile Duct Cancer Drug Import and Export
• 5.8 India Bile Duct Cancer Drug Market Analysis
  • 5.8.1 India Bile Duct Cancer Drug Production
  • 5.8.2 India Bile Duct Cancer Drug Revenue
  • 5.8.3 Key Manufacturers in India
  • 5.8.4 India Bile Duct Cancer Drug Import and Export

6 Bile Duct Cancer Drug Segment Market Analysis (by Type)

• 6.1 Global Bile Duct Cancer Drug Production by Type
• 6.2 Global Bile Duct Cancer Drug Revenue by Type
• 6.3 Bile Duct Cancer Drug Price by Type

7 Bile Duct Cancer Drug Segment Market Analysis (by Application)

• 7.1 Global Bile Duct Cancer Drug Consumption by Application
• 7.2 Global Bile Duct Cancer Drug Consumption Market Share by Application (2014-2019)

8 Bile Duct Cancer Drug Major Manufacturers Analysis

• 8.1 Ariad Pharmaceuticals, Inc.
  • 8.1.1 Ariad Pharmaceuticals, Inc. Bile Duct Cancer Drug Production Sites and Area Served
  • 8.1.2 Ariad Pharmaceuticals, Inc. Product Introduction, Application and Specification
  • 8.1.3 Ariad Pharmaceuticals, Inc. Bile Duct Cancer Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.1.4 Main Business and Markets Served
• 8.2 ArQule, Inc.
  • 8.2.1 ArQule, Inc. Bile Duct Cancer Drug Production Sites and Area Served
  • 8.2.2 ArQule, Inc. Product Introduction, Application and Specification
  • 8.2.3 ArQule, Inc. Bile Duct Cancer Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.2.4 Main Business and Markets Served
• 8.3 Array BioPharma Inc.
  • 8.3.1 Array BioPharma Inc. Bile Duct Cancer Drug Production Sites and Area Served
  • 8.3.2 Array BioPharma Inc. Product Introduction, Application and Specification
  • 8.3.3 Array BioPharma Inc. Bile Duct Cancer Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.3.4 Main Business and Markets Served
• 8.4 Arrien Pharmaceuticals, LLC
  • 8.4.1 Arrien Pharmaceuticals, LLC Bile Duct Cancer Drug Production Sites and Area Served
  • 8.4.2 Arrien Pharmaceuticals, LLC Product Introduction, Application and Specification
  • 8.4.3 Arrien Pharmaceuticals, LLC Bile Duct Cancer Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.4.4 Main Business and Markets Served
• 8.5 Aslan Pharmaceuticals Pte. Ltd.
  • 8.5.1 Aslan Pharmaceuticals Pte. Ltd. Bile Duct Cancer Drug Production Sites and Area Served
  • 8.5.2 Aslan Pharmaceuticals Pte. Ltd. Product Introduction, Application and Specification
  • 8.5.3 Aslan Pharmaceuticals Pte. Ltd. Bile Duct Cancer Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.5.4 Main Business and Markets Served
• 8.6 Bavarian Nordic A/S
  • 8.6.1 Bavarian Nordic A/S Bile Duct Cancer Drug Production Sites and Area Served
  • 8.6.2 Bavarian Nordic A/S Product Introduction, Application and Specification
  • 8.6.3 Bavarian Nordic A/S Bile Duct Cancer Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.6.4 Main Business and Markets Served
• 8.7 Bayer AG
  • 8.7.1 Bayer AG Bile Duct Cancer Drug Production Sites and Area Served
  • 8.7.2 Bayer AG Product Introduction, Application and Specification
  • 8.7.3 Bayer AG Bile Duct Cancer Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.7.4 Main Business and Markets Served
• 8.8 Blueprint Medicines Corporation
  • 8.8.1 Blueprint Medicines Corporation Bile Duct Cancer Drug Production Sites and Area Served
  • 8.8.2 Blueprint Medicines Corporation Product Introduction, Application and Specification
  • 8.8.3 Blueprint Medicines Corporation Bile Duct Cancer Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.8.4 Main Business and Markets Served
• 8.9 Boehringer Ingelheim GmbH
  • 8.9.1 Boehringer Ingelheim GmbH Bile Duct Cancer Drug Production Sites and Area Served
  • 8.9.2 Boehringer Ingelheim GmbH Product Introduction, Application and Specification
  • 8.9.3 Boehringer Ingelheim GmbH Bile Duct Cancer Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.9.4 Main Business and Markets Served
• 8.10 Boston Biomedical, Inc.
  • 8.10.1 Boston Biomedical, Inc. Bile Duct Cancer Drug Production Sites and Area Served
  • 8.10.2 Boston Biomedical, Inc. Product Introduction, Application and Specification
  • 8.10.3 Boston Biomedical, Inc. Bile Duct Cancer Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.10.4 Main Business and Markets Served
• 8.11 Bristol-Myers Squibb Company
• 8.12 Celgene Corporation
• 8.13 CellAct Pharma GmbH
• 8.14 Cellceutix Corporation
• 8.15 Cellular Biomedicine Group, Inc.
• 8.16 Concordia Healthcare Corp.

9 Development Trend of Analysis of Bile Duct Cancer Drug Market

• 9.1 Global Bile Duct Cancer Drug Market Trend Analysis
  • 9.1.1 Global Bile Duct Cancer Drug Market Size (Volume and Value) Forecast 2019-2025
• 9.2 Bile Duct Cancer Drug Regional Market Trend
  • 9.2.1 North America Bile Duct Cancer Drug Forecast 2019-2025
  • 9.2.2 Europe Bile Duct Cancer Drug Forecast 2019-2025
  • 9.2.3 China Bile Duct Cancer Drug Forecast 2019-2025
  • 9.2.4 Japan Bile Duct Cancer Drug Forecast 2019-2025
  • 9.2.5 Southeast Asia Bile Duct Cancer Drug Forecast 2019-2025
  • 9.2.6 India Bile Duct Cancer Drug Forecast 2019-2025
• 9.3 Bile Duct Cancer Drug Market Trend (Product Type)
• 9.4 Bile Duct Cancer Drug Market Trend (Application)
• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.3 Bile Duct Cancer Drug Customers

11 Market Dynamics

• 11.1 Market Trends
• 11.2 Opportunities
• 11.3 Market Drivers
• 11.4 Challenges
• 11.5 Influence Factors

12 Conclusion

13 Appendix

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List